Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Tax Provisions (2018 - 2022)

Regenxbio has reported Tax Provisions over the past 5 years, most recently at -$43000.0 for Q4 2022.

  • Quarterly results put Tax Provisions at -$43000.0 for Q4 2022, down 100.32% from a year ago — trailing twelve months through Dec 2022 was -$84000.0 (down 100.63% YoY), and the annual figure for FY2023 was -$152000.0, down 80.95%.
  • Tax Provisions for Q4 2022 was -$43000.0 at Regenxbio, down from -$41000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for RGNX hit a ceiling of $13.4 million in Q4 2021 and a floor of -$2.4 million in Q4 2019.
  • Median Tax Provisions over the past 5 years was -$22000.0 (2020), compared with a mean of $1.4 million.
  • Biggest five-year swings in Tax Provisions: surged 340.19% in 2020 and later crashed 1125.0% in 2022.
  • Regenxbio's Tax Provisions stood at $1.6 million in 2018, then crashed by 247.5% to -$2.4 million in 2019, then surged by 340.19% to $5.7 million in 2020, then surged by 133.38% to $13.4 million in 2021, then plummeted by 100.32% to -$43000.0 in 2022.
  • The last three reported values for Tax Provisions were -$43000.0 (Q4 2022), -$41000.0 (Q1 2022), and $13.4 million (Q4 2021) per Business Quant data.